Sunshine Biopharma Inc (SBFM)

[kingbee]

Do you realize that Adva-27a is a modification of etoposide, which is a very successful drug? Adva-27a has been outperforming etoposide during in vitro studies that were done last year. We will next learn about the mice studies that are finished. I know the mice studies are finished but not yet published because the last 10q made reference to IND studies and a Fast Track application for Adva-27a.

There were no trials that failed in France. Sunshine Biopharma now has the intellectual property rights for this drug and finally has the money to move forward.

I suspect that Amplia Pharmatek of Laval has been working along Sunshine since 2012 and duplicated their experiments last year that should clear the way for Fast Track status. I could be totally wrong about that but that would make sense.

This is not some novel drug that is unique. This is a modification that makes a widely used and successful drug more effective.